Since UCP2 is a critical regulator of cellular glucose and lipid metabolism [52], we propose that FME may ameliorate metabolic disorders of obese mice partly though the regulation of PPARα signaling pathway. The gene discussed is UCP2; the disease is Other metabolic disease.